Skip to content

维尔沃通讯

US · WEAV #3634 按市值排名 上市于 2021
7.40 +0.01 +0.14%
实时 - 追踪5344个代码 - 心跳于147秒前 · 2026-10-16 19:30

估值 各估值倍数与自身5年区间的对比

市净率 6.98 处于历史正常水平 第54百分位
5年平均 6.77 · 在Health Information Services中排名第35/41
市盈率 -27.30 低于历史水平 第11百分位
5年平均 -17.27 · 前瞻 -34.27
市销率 2.30 低于历史水平 第25百分位
5年平均 3.58 · 前瞻 2.03 · 在Health Information Services中排名第22/42

同业对比 Health Information Services

公司 市值 市盈率(TTM) 市净率 股息率
维尔沃通讯 (WEAV) 595.33M -27.41 7.01 0.00%
Veeva Systems (VEEV) 50.25B 50.88 6.76 0.00%
BrightSpring Health Services (BTSG) 12.04B 36.89 5.88 0.00%
Tempus AI (TEM) 11.68B -44.94 26.24 0.00%
Hinge Health (HNGE) 8.00B 74.11 23.24 0.00%
HealthEquity (HQY) 7.61B 33.22 3.83 0.00%

StockVane 追踪范围内同行业的其他公司。

Morningstar

★★★☆☆ 合理价值8.09 经济护城河None 不确定性Very High

当前股价低于晨星合理价值估算9.3%。

合理价值

Weave Communications Inc earns a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 9% discount to our quantitative fair value estimate of $8.09 per share; however, caution is warranted due to this estimate's very high uncertainty rating.

The firm's balance sheet increases our valuation estimate. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. For example, the firm's EBITDA/interest coverage ratio of -1.6 falls in the bottom 20% compared with peers globally. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. We believe this is a sign that shares could be cheap.

Alternatively, the company's valuation metrics are potentially concerning. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to EBITDA ratio of 39.6, a core component of valuation, falls in the top 20% compared with global peers. This suggests that the value of its enterprise value, or the value of its shares and debt, is a high multiple of the generated EBITDA. Despite our favorable price/fair value ratio, this characteristic is a negative attribute.

经济护城河

With its quantitative economic moat rating of none, this business is unlikely to consistently outearn its cost of capital without structural protection from competition. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

作者:Quantitative Equity Report

报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

维尔沃通讯 讨论区 0 条评论

发表评论